DE68926712D1 - Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff - Google Patents

Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff

Info

Publication number
DE68926712D1
DE68926712D1 DE68926712T DE68926712T DE68926712D1 DE 68926712 D1 DE68926712 D1 DE 68926712D1 DE 68926712 T DE68926712 T DE 68926712T DE 68926712 T DE68926712 T DE 68926712T DE 68926712 D1 DE68926712 D1 DE 68926712D1
Authority
DE
Germany
Prior art keywords
gene
coding
malaria vaccine
against human
human malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68926712T
Other languages
English (en)
Other versions
DE68926712T2 (de
Inventor
Louis Miller
David Kaslow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE68926712D1 publication Critical patent/DE68926712D1/de
Publication of DE68926712T2 publication Critical patent/DE68926712T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68926712T 1988-05-02 1989-04-20 Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff Expired - Lifetime DE68926712T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18891888A 1988-05-02 1988-05-02
PCT/US1989/001618 WO1989010936A1 (en) 1988-05-02 1989-04-20 Gene for encoding a human malaria vaccine antigen

Publications (2)

Publication Number Publication Date
DE68926712D1 true DE68926712D1 (de) 1996-07-25
DE68926712T2 DE68926712T2 (de) 1997-04-17

Family

ID=22695095

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926712T Expired - Lifetime DE68926712T2 (de) 1988-05-02 1989-04-20 Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff

Country Status (8)

Country Link
EP (1) EP0418310B1 (de)
JP (1) JP2812759B2 (de)
AT (1) ATE139537T1 (de)
AU (1) AU619312B2 (de)
CA (1) CA1340963C (de)
DE (1) DE68926712T2 (de)
IL (1) IL90134A (de)
WO (1) WO1989010936A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217898A (en) * 1988-05-02 1993-06-08 The United States Of America As Represented By The Secretary Of Health And Human Services Expression of the P. falciparum transmission-blocking antigen in yeast
WO1990002802A2 (en) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Viral nucleotide sequences
AU1588092A (en) * 1991-02-22 1992-09-15 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Transmission blocking vaccine against malaria
US5527700A (en) * 1992-07-10 1996-06-18 The United States Of America As Represented By The Department Of Health And Human Services Target antigens of transmission blocking antibodies for malaria parasites
AU675445B2 (en) * 1992-07-10 1997-02-06 United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Target antigens of transmission blocking antibodies for malaria parsites
US7192934B1 (en) 1997-05-01 2007-03-20 The United States Of America As Represented By The Department Of Health And Human Services Vaccines for blocking transmission of Plasmodium vivax
US7407658B2 (en) 1997-05-01 2008-08-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Vaccines for blocking transmission of plasmodium vivax
EP1034275A1 (de) * 1997-12-05 2000-09-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Impfstoffe zur blockierung der übertragung von plasmodium vivax
US11254134B2 (en) 2018-07-13 2022-02-22 Hewlett-Packard Development Company, L.P. Fluid supply components comprising valves

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632909A (en) * 1983-10-31 1986-12-30 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies which block infectivity of malarial parasites to mosquitoes
GB8404493D0 (en) * 1984-02-21 1984-03-28 Hope I A Malaria vaccines
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
EP0252098A4 (de) * 1985-12-24 1989-11-29 Inst Medical W & E Hall Asexuelle blutphasenantigene von plasmodium falciparum.

Also Published As

Publication number Publication date
AU3763789A (en) 1989-11-29
DE68926712T2 (de) 1997-04-17
EP0418310A1 (de) 1991-03-27
EP0418310A4 (en) 1991-11-27
IL90134A0 (en) 1989-12-15
JP2812759B2 (ja) 1998-10-22
AU619312B2 (en) 1992-01-23
JPH03503122A (ja) 1991-07-18
IL90134A (en) 1997-06-10
CA1340963C (en) 2000-04-18
ATE139537T1 (de) 1996-07-15
EP0418310B1 (de) 1996-06-19
WO1989010936A1 (en) 1989-11-16

Similar Documents

Publication Publication Date Title
DK0614465T3 (da) Hybridprotein mellem CS fra Plasmodium og HBsAg
FR2697022B1 (fr) Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
HUT37460A (en) Cloning dna for malaria antigens
ATE205254T1 (de) Transformierender wachstumsfaktor alpha h1
DE68926712T2 (de) Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff
DE60038971D1 (de) Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
ATE405662T1 (de) Verfahren zur herstellung rekombinanter adenovirus-genome
ATE175417T1 (de) Leadersequenz zur induzierung einer posttranslationalen modifikation von polypeptiden in bakterien, sowie dafür kodierendes gen
ZA851305B (en) Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
AU2992489A (en) Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
ATE214097T1 (de) Die ansteckung blockierende malariaimpfstoffe
PT97876A (pt) Processo para a producao de uma nova proteina
PL288140A1 (en) Polypeptide, vaccine, expression vector, method of immunizing human organisms, method of obtaining polypeptide and method of obtaining such vaccine and expression vector
BR8807888A (pt) Genes clonados codificando antigenos de coccidiose aviaria que induzem uma resposta mediada por celulas e metodo de producao dos mesmos
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
KR900701831A (ko) 열대열 말라리아 원충의 분열소체 표면 항원의 대립형질 변이주
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
TH3773A (th) วัคซีนป้องกันมาเลเรีย
ATE144537T1 (de) Merozoit-oberflächen-plasmodium-falciparum- antigen
CA2102624A1 (en) Transmission-blocking vaccine against malaria

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: MEISSNER, BOLTE & PARTNER, 90402 NUERNBERG